JD Health and AstraZeneca start strategic cooperation

2020-11-18
|
Michael Liang

On November 17, JD Health and AstraZeneca, the world's leading multinational pharmaceutical company, reached a strategic cooperation.


The two parties announced that they will fully integrate AstraZeneca’s international experience and innovative medical solutions in the treatment of various diseases and JD Health’s medical supply chain, Internet medical, health management and other strong businesses, and explore the new "Internet Plus" service model.


They aim to provide patients with better online medical and health services and to contribute to the digital transformation of China's medical and health industry and the upgrading of its national health service system.


RELATED ARTICLES

Phase III clinical trial of China's covid-19 inactivated vaccine launched in Argentina
2020-08-24
|
Covid-19 , Medical care , Argentina

China's first COVID-19 vaccine produced by insect cells obtained clinical trial approval
2020-08-24
|
Pharmaceutical , Vaccine , Covid-19 , Biotech

China started emergency use of Covid-19 vaccine on July 22
2020-08-23
|
Covid-19 , Medical care , Vaccine

Hillhouse Capital plans to invest over US$830 million in JD Health
2020-08-17
|
e-commerce , PEVC , Financing

Yantai Stomatological Hospital settled in JD.com’s dental health center
2020-08-15
|
Medical care , Healthcare , Hospital

JD Health becomes the youngest unicorn: Hurun
2020-08-09
|
Unicorn , Healthcare

New policies on new energy bus subsidies may be introduced: official
2020-08-08
|
Covid-19 , New energy vehicle

Satellite internet firm ADA Spacecloses RMB150m Series A+ round
2020-07-09
|
Aerospace , PEVC , Covid-19 , Satellite internet

JD Health and Eisai China reached a strategic cooperation for the elderly
2020-06-08
|
Senior care , Health care , Medical care , e-commerce

JD Health's nucleic acid group testing open for appointments, covering 31 cities
2020-04-29
|
Health , Covid-19
China SDG